Perron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.50 M
as on 05-07-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 5.28%
(FY 2019)
- Profit -15.36%
(FY 2019)
- Ebitda -24.59%
(FY 2019)
- Net Worth 14.52%
(FY 2019)
- Total Assets 27.82%
(FY 2019)
About Perron Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anita and Tarun Garg serve as directors at the Company.
- CIN/LLPIN
U24233DL2008PTC176181
- Company No.
176181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Perron Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita  | Director | 27-Oct-2016 | Current |
| Tarun Garg | Director | 01-Apr-2008 | Current |
Financial Performance and Corporate Structure Insights of Perron Pharmaceuticals.
Perron Pharmaceuticals Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 5.28% increase. The company also saw a substantial fall in profitability, with a 15.36% decrease in profit. The company's net worth Soared by an impressive increase of 14.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perron Pharmaceuticals?
In 2019, Perron Pharmaceuticals had a promoter holding of 66.00% and a public holding of 34.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
2 years 8 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Perron Pharmaceuticals?
Unlock and access historical data on people associated with Perron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
